More news, no ads
LEARN MORE18 May 2022
The company has brought its R&D teams together in London.
04 May 2022
Meanwhile, it expects sales of its Covid-19 vaccine to decline in 2022.
28 April 2022
There are an estimated 390 million infections each year.
22 April 2022
Growth Works and Eastern AHSN helped the company as it scales.
21 April 2022
The Cambridge Science Park company is also working with Roche Diagnostics on a liver cancer pilot study.
20 April 2022
It has developed and characterised Affimer proteins against the first target for AffyXell.
14 April 2022
An interview with Prof Steve Jackson and CEO Robert Johnson
13 April 2022
It extends the total raised to £7m.
31 March 2022
The Cambridge biotech wants to ‘drive a revolution in biology’.
31 March 2022
New CEO and new head of UK R&D confirmed.
10 March 2022
Results have been published from the University of Oxford RECOVERY trial.
10 March 2022
Robert Johnson previously co-founded Boston-based gene therapy company Affinia Therapeutics.
08 March 2022
Prime Minister Boris Johnson announce the funding at the Global Pandemic Preparedness Summit.
04 March 2022
The discovery could help us explore the earliest events in our development.
03 March 2022
Dr Tony Cooke has become chair of the scientific advisory board for The Laboratory and Testing Industry Organisation.
03 March 2022
It follows a seed funding round of about £3m.
19 February 2022
Mr Javid visited the campus as part of a tour of the East of England.
11 February 2022
It is the first new treatment in this indication for years.
10 February 2022
Pascal Soriot was speaking as the company revealed stellar results from a ‘landmark’ year.
10 February 2022
It will make biomarker testing faster, more affordable and more accessible.